↓ Skip to main content

Is My Patient Taking an Unsafe Dietary Supplement?

Overview of attention for article published in The AMA Journal of Ethic, May 2022
Altmetric Badge

Mentioned by

news
1 news outlet
twitter
7 X users
facebook
1 Facebook page

Readers on

mendeley
2 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Is My Patient Taking an Unsafe Dietary Supplement?
Published in
The AMA Journal of Ethic, May 2022
DOI 10.1001/amajethics.2022.390
Pubmed ID
Authors

Ilisa B G Bernstein, Karin L Bolte

Abstract

Dietary supplements do not require premarket approval by the US Food and Drug Administration (FDA), yet they can have side effects; interact with medications, food, or other supplements; or be unsafe, so it is important for clinicians to discuss dietary supplement use with patients. This article provides an overview of dietary supplement requirements related to safety, manufacturing, labeling, advertising, and adverse event reporting; discusses tainted supplements and the FDA's and Federal Trade Commission's enforcement actions against dietary supplements; and offers recommendations to clinicians on matters of key clinical and ethical importance during clinical encounters.

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 2 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 2 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 1 50%
Unknown 1 50%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 1 50%
Unknown 1 50%